We are live on ! Find out more

2,688 hedge funds and large institutions have $143B invested in Merck in 2021 Q1 according to their latest regulatory filings, with 143 funds opening new positions, 1,268 increasing their positions, 1,009 reducing their positions, and 132 closing their positions.

New
Increased
Maintained
Reduced
Closed

26% more repeat investments, than reductions

Existing positions increased: 1,268 | Existing positions reduced: 1,009

18% more call options, than puts

Call options by funds: $1.48B | Put options by funds: $1.25B

8% more first-time investments, than exits

New positions opened: 143 | Existing positions closed: 132

0.69% less ownership

Funds ownership: 74.14% → 73.46% (-0.69%)

1% less funds holding

Funds holding: 2,710 → 2,688 (-22)

7% less capital invested

Capital invested by funds: $153B → $143B (-$10.1B)

23% less funds holding in top 10

Funds holding in top 10: 111 → 85 (-26)

Holders
2,688
Holders Change
-22
Holders Change %
-0.81%
% of All Funds
47.06%
Holding in Top 10
85
Holding in Top 10 Change
-26
Holding in Top 10 Change %
-23.42%
% of All Funds
1.49%
New
143
Increased
1,268
Reduced
1,009
Closed
132
Calls
$1.48B
Puts
$1.25B
Net Calls
+$226M
Net Calls Change
+$36.8M

MRK Hedge Fund Activity: Q1 2021 in Review

2,688 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q1 2021, worth a combined $143B — down 6.6% from $153B a quarter earlier.

Buyers outnumbered sellers: 143 funds opened new MRK positions and 132 closed out — a net gain of 11 holders — while 1,268 added to existing stakes and 1,009 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.3B. The largest seller was Berkshire Hathaway, cutting an estimated $836M.

  • 2,688 institutional investors held Merck (MRK) as of Q1 2021, down from 2,710 in Q4 2020.
  • Funds reported $143B of Merck stock for Q1 2021, down 6.6% quarter-over-quarter.
  • 143 funds opened new Merck positions in Q1 2021 and 132 closed out, a net change of +11 holders.
  • The largest Merck buyer in Q1 2021 was Vanguard Group, an estimated $1.3B added.
  • The largest Merck seller in Q1 2021 was Berkshire Hathaway, an estimated $836M sold.

Based on aggregated 13F filings for Q1 2021.